Progress in Neurodegeneration : (Record no. 60962)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 08947nam a22005173i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC3020673 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729124140.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2009 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781617285707 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781607413172 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC3020673 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL3020673 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10680811 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)665795359 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC365 -- .A95 2009eb |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.8/0471 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Avila-Costa, Maria Rosa. |
| 245 10 - TITLE STATEMENT | |
| Title | Progress in Neurodegeneration : |
| Remainder of title | The Role of Metals. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | New York : |
| Name of producer, publisher, distributor, manufacturer | Nova Science Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2009. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2009. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (398 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Neurodegenerative Diseases - Laboratory and Clinical Research Series |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- PROGRESS IN NEURODEGENERATION: THE ROLE OF METALS -- PROGRESS IN NEURODEGENERATION: THE ROLE OF METALS -- Dedication -- Contents -- Acknowledgments -- Preface -- Introduction -- Chapter 1 The Nervous System and Brain Damage -- 1. The Nervous System -- 1.1. Central Nervous System -- 1.1.1. Neurons -- 1.1.2. Synapse -- 1.1.3. Neuroglial Cells -- 1.2. Brain Damage -- References -- Chapter 2 Neurodegenerative Diseases -- 2.1. Huntington Disease -- 2.2. Parkinson Disease -- 2.3. Alzheimer Disease -- 2.4. Amyotrophic Lateral Sclerosis -- Final Considerations -- References -- Chapter 3 Metals, Toxicity and Neurodegeneration -- 3.1. Entrance of Metals to the Brain -- 3.2. Metal Transport and Toxicity to the Brain Barriers -- 3.3. Oxidative Stress -- 3.3.1. Metal Ions and Oxidative Stress -- 3.3.2. Oxidative Stress in AD -- 3.3.3. Oxidative Stress in PD -- 3.3.4. Oxidative Stress in ALS -- 3.3.5. Oxidative Stress in HD -- 3.4. Mitochondrial Alterations -- 3.5. Common Mechanisms of Neurotoxicity -- 3.5.1. Excitotoxicity -- 3.5.2. Apoptosis -- 3.5.3. Necrosis -- 3.5.4. Glial Activation -- 3.5.5. Inflammation -- 3.5.6. Cytokines -- Cytokine Actions on Neurons -- Cytokine Actions on Glia -- 3.6. Metals and the Activation of Signalling Pathways -- 3.6.1. Protein Aggregation in Neurodegeneration -- Final Considerations -- References -- Chapter 4 Aluminum -- 4.1. Sources of Aluminum -- 4.1.1. Environmental Exposure -- 4.1.2. Dietary Exposure -- 4.1.3. Iatrogenic Exposure -- 4.1.4. Occupational Exposure -- 4.2. Aluminum Entry -- 4.2.1. Distribution -- 4.3. Mechanisms by Which Aluminum Causes Neuronal Damage -- 4.3.1. Aluminum Oxidation -- 4.3.2. Impairment of Glia Function -- 4.3.3. Inflammatory Response -- 4.3.4. Apoptosis -- 4.3.5. Conformational Changes of Proteins -- 4.3.6. Neurotransmission Impairment. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 4.4. Aluminum and Neurodegeneration -- 4.4.1. Dialysis Encephalopathy -- 4.4.2. Encephalopathy with Epilepsy -- 4.4.3. Alzheimer Disease -- 4.4.4. Parkinson Disease -- 4.4.5. Multiple Sclerosis -- Final Considerations -- References -- Chapter 5 Manganese -- 5.1. Manganese Absorption -- 5.2. Manganese Transport -- 5.3. Manganese and the Central Nervous System -- 5.3.1. γ-Aminobutyric Acid (GABA) -- 5.3.2. Glutamate (Glu) -- 5.3.3. Dopamine (DA) -- 5.4. Manganism -- 5.5. Oxidative Stress -- 5.6. Apoptotic Neuronal Death -- 5.7. Excitotoxicity -- 5.8. Neuroinflammation -- References -- Chapter 6 Cadmium -- 6.1. General Description -- 6.1. Sources -- 6.2. Routes of Exposure -- 6.2.1. Air -- 6.2.2. Drinking-water -- 6.2.3. Food -- 6.3. Absorption, Distribution and Excretion -- 6.3.1. Absorption -- 6.3.3. Distribution -- 6.3.4. Excretion -- 6.4. Cadmium Toxicity -- 6.4.1. Access of Cd to the brain -- 6.4.2. Neurotoxicity -- 6.4.3. Cadmium Neuropathology -- 6.5. Mechanisms of Cd Neurotoxicity -- 6.6. Cadmium and Neurodegeneration -- Final Considerations -- References -- Chapter 7 Zinc -- 7.1. General Description -- 7.1.1. Sources -- 7.2. Absorption -- 7.2.1. Inhalation Exposure -- 7.2.2. Oral Exposure -- 7.2.3. Dermal Exposure -- 7.3. Distribution -- 7.3.1. Metabolism -- 7.3.2. Excretion -- 7.4. Zinc in the Brain -- 7.4.1. Zinc and Brain Function -- 7.4.2. Zinc Transport into the Brain -- 7.4.3. Zinc Release from Neuron Terminals -- 7.5. Zinc Neurotoxicity -- 7.5.1. Mechanism of Zn-induced Neurotoxicity -- 7.6. Diseases Associated with Zinc-Mediated Neuronal Death -- 7.6.1. Ischemia -- 7.6.2. Seizures -- 7.7. Neurodegenerative Diseases -- 7.7.1. Alzheimer Disease -- 7.7.2. Other Neurodegenerative Diseases -- 7.7.3. Brain Aging -- Final Considerations -- References -- Chapter 8 Vanadium -- 8.1. General Description -- 8.2. Sources -- 8.2.1. Air. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 8.2.2. Soil -- 8.2.3. Water -- 8.2.4. Food -- 8.2.5. Occupational Exposure -- 8.3. Absorption, Distribution and Excretion -- 8.4. General Toxicity -- 8.4.1. Mechanism of Action -- 8.5. Nervous System Effects -- 8.5.1. Olfactory Bulb -- 8.5.2. Cerebral Ventricles -- 8.5.3. Basal Ganglia -- 8.5.4. Hippocampus -- Final Considerations -- References -- Chapter 9 Lead -- 9.1. General Description -- 9.2. Sources of Lead Exposure -- 9.2.1. Air -- 9.2.2. Water -- 9.2.3. Soil -- 9.2.4. Paint -- 9.2.5. Other Sources -- 9.3. Absorption, Distribution, Metabolism, and Excretion -- 9.4. Health Effects -- 9.5. Lead Neurotoxicity -- 9.5.1. Mechanism of Pb-induced Neurotoxicity -- 9.5.2. Pb and Neurotransmission -- 9.6. Lead and Neurodegenerative Diseases -- Final Considerations -- References -- Chapter 10 Iron -- 10.1. General Description -- 10.2. Sources of Iron Exposure -- 10.2.1. Air -- 10.2.2. Water -- 10.2.3. Food -- 10.3. Absorption, Distribution, Metabolism, and Excretion -- 10.4. Health Effects -- 10.5. Iron in the Brain -- 10.5.1. Iron Transport to Brain -- 10.6. Iron Neurotoxicity -- 10.6.1. Mechanism of Fe-induced Neurotoxicity -- 10.6.2. Fe and Free Radicals -- 10.7. Iron and Neurodegenerative Diseases -- 10.7.1. Alzheimer Disease -- 10.7.2. Parkinson Disease -- 10.7.3. Other Neurological Diseases -- 10.7.3.1. Aceruloplasminemia -- 10.7.3.2. Neuroferritinopathy -- 10.7.3.3. Friedreich Ataxia -- 10.8. Neurodegeneration with Brain Iron Accumulation (NBIA) -- 10.8.1. Huntington Disease and Multiple Sclerosis -- Final Considerations -- References -- Chapter 11 Mercury -- 11.1. General Description -- 11.2. Sources of Mercury Exposure -- 11.2.1. Air -- 11.2.2. Water -- 11.2.3. Food -- 11.2.3.1. Food of Animal Origin -- 11.2.3.2. Food of Plant Origin -- 11.2.4. Pharmaceuticals and Utility Products. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 11.3. Absorption, Distribution, Metabolism, and Excretion -- 11.4. Toxicity -- 11.4.1. Mechanisms of Mercury Toxicity -- 11.5. Mercury in the Brain -- 11.5.1. Mercury Transport to Brain -- 11.5.2. Mercury Neurotoxicity -- 11.6. Mechanism of Mercury-Induced Neurotoxicity -- 11.6.1. Oxidative Stress -- 11.6.2. Neurotransmission -- 11.7. Mercury and Neurodegenerative Diseases -- 11.7.1. Alzheimer Disease -- 11.7.2. Parkinson Disease -- 11.7.3. Amyotrophic Lateral Sclerosis -- 11.7.4. Other neurological Diseases -- 11.7.4.1. Multiple Sclerosis -- 11.7.4.2. Acrodynia -- 11.7.4.3. Autism -- Final Considerations -- References -- Chapter 12 Copper -- 12.1. General Description -- 12.2. Sources of Copper Exposure -- 12.2.1. Air -- 12.2.2. Water -- 12.2.3. Food -- 12.3. Absorption, Distribution, Metabolism, and Excretion -- 12.4. Toxicity -- 12.4.1. Mechanisms of Copper Toxicity -- 12.5. Copper in the Brain -- 12.5.1. Copper Transport to Brain -- 12.5.2. Copper Neurotoxicity -- 12.6. Mechanism of Copper-Induced Neurotoxicity -- 12.6.1. Oxidative Stress -- 12.6.2. Neurotransmission -- 12.7. Copper and Neurodegenerative Diseases -- 12.7.1. Alzheimer Disease -- 12.7.2. Parkinson Disease -- 12.7.3. Amyotrophic Lateral Sclerosis -- 12.7.4. Other Neurological Diseases -- 12.7.4.1. Wilson Disease -- 12.7.4.2. Menkes Disease -- 12.7.4.3. Prion Diseases -- Final Considerations -- References -- Index -- Blank Page. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nervous system -- Degeneration. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Metals -- Toxicology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neurotoxicology. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Martinez, Veronica Anaya. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Avila-Costa, Maria Rosa |
| Title | Progress in Neurodegeneration |
| Place, publisher, and date of publication | New York : Nova Science Publishers, Incorporated,c2009 |
| International Standard Book Number | 9781607413172 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Neurodegenerative Diseases - Laboratory and Clinical Research Series |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020673">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020673</a> |
| Public note | Click to View |
No items available.